MedTrace Logo

PK TDF in Thai HIV-infected Children

NCT02404259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-03-31

No results posted yet for this study

Summary

This study will assess the pharmacokinetics of TDF in Thai HIV-infected children

Conditions

Interventions

DRUG

TDF (Tenofovir)

DRUG

Efavirenz

DRUG

lopinavir/ritonavir, atazanavir/ritonavir

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER

  • Khon Kaen University

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Thanyawee Puthanakit, MD · HIV-NAT and Chulalongkorn University

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02404259 on ClinicalTrials.gov